Platelet function in older atrial fibrillation patients
Part of Heart & circulation clinical trials.
This study looks at how blood platelets work in older adults with atrial fibrillation who are having a Watchman procedure. Researchers want to understand platelet function better to improve care.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You must have atrial fibrillation (an irregular heartbeat condition).
- You must be scheduled for a Watchman procedure (a device placed in the heart to prevent stroke).
- You should not be taking antiplatelet medication like aspirin or clopidogrel.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study looks at how to better predict both stroke risk and bleeding risk in people with atrial fibrillation. It may help doctors choose safer blood-thinner treatment and follow-up plans.
This study follows people with atrial fibrillation to see how well blood-thinning medications work and what outcomes they experience over time. It aims to improve treatment guidance for patients with this common heart rhythm condition.
This trial tests how well blood thinners (anticoagulants) work to dissolve clots in the heart of people with atrial fibrillation (an irregular heartbeat). It aims to find the best treatment for these clots before more serious complications occur.
This study looks at early changes in the heart related to atrial fibrillation (AF) using health data and biomarkers. It aims to find better ways to predict or understand AF, especially around procedures like ablation or cardioversion.
This study is looking at whether two blood tests (hs Troponin I and NT-proBNP) can help predict if people with a permanent pacemaker will develop atrial fibrillation, a common heart rhythm problem. If you need a pacemaker, you may be able to join and help researchers learn more.
This registry study follows people with atrial fibrillation to learn which risk factors are linked to stroke or blood clots traveling through the body. Your information helps improve how doctors predict risk and choose prevention strategies.
Hear when a new Atrial fibrillation trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.